642 related articles for article (PubMed ID: 12658281)
1. Alzheimer's disease: the cholesterol connection.
Puglielli L; Tanzi RE; Kovacs DM
Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
[TBL] [Abstract][Full Text] [Related]
2. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
[TBL] [Abstract][Full Text] [Related]
3. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
Fan J; Donkin J; Wellington C
Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
[TBL] [Abstract][Full Text] [Related]
4. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol and Alzheimer's disease--is there a relation?
Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I
Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384
[TBL] [Abstract][Full Text] [Related]
6. Brain cholesterol, statins and Alzheimer's Disease.
Kirsch C; Eckert GP; Koudinov AR; Müller WE
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S113-9. PubMed ID: 14574624
[TBL] [Abstract][Full Text] [Related]
7. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol and pathological processes in Alzheimer's disease.
Yanagisawa K
J Neurosci Res; 2002 Nov; 70(3):361-6. PubMed ID: 12391598
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease?
Michikawa M
J Neurosci Res; 2003 Apr; 72(2):141-6. PubMed ID: 12671988
[TBL] [Abstract][Full Text] [Related]
10. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol in Alzheimer's disease and other amyloidogenic disorders.
Harris JR; Milton NG
Subcell Biochem; 2010; 51():47-75. PubMed ID: 20213540
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
13. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.
Kuo YM; Emmerling MR; Bisgaier CL; Essenburg AD; Lampert HC; Drumm D; Roher AE
Biochem Biophys Res Commun; 1998 Nov; 252(3):711-5. PubMed ID: 9837771
[TBL] [Abstract][Full Text] [Related]
14. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A
Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
Wyss-Coray T
J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
[TBL] [Abstract][Full Text] [Related]
16. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
Dolev I; Michaelson DM
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease. Bad for the heart, bad for the mind?
Marx J
Science; 2001 Oct; 294(5542):508-9. PubMed ID: 11641483
[No Abstract] [Full Text] [Related]
18. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol modulates amyloid beta-peptide's membrane interactions.
Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
[TBL] [Abstract][Full Text] [Related]
20. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?
Ledesma MD; Dotti CG
FEBS Lett; 2006 Oct; 580(23):5525-32. PubMed ID: 16814780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]